Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.

Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.

Item
http://www.wikidata.org/entity/Q37679175
Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.Prevalence of the Janus kinase 2 V617F mutation in Philadelphia-negative myeloproliferative neoplasms in a Portuguese population.Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria.Recommendations on the use of ruxolitinib for the treatment of myelofibrosis.Diagnostic impact of the 2016 revised who criteria for polycythemia vera.Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis.The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature.Evaluation of vascular events in patients with myeloproliferative syndromes and mutations of either the januskinase-2 or calreticulin gene at the university hospital Krems from 2008 to 2015.Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis.Recent advances in the diagnosis and management of primary myelofibrosis.
P2860

Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms.

Item
http://www.wikidata.org/entity/Q37679175
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnosis, risk stratification ...... myeloproliferative neoplasms.
@en
Diagnosis, risk stratification ...... myeloproliferative neoplasms.
@nl
type
label
Diagnosis, risk stratification ...... myeloproliferative neoplasms.
@en
Diagnosis, risk stratification ...... myeloproliferative neoplasms.
@nl
prefLabel
Diagnosis, risk stratification ...... myeloproliferative neoplasms.
@en
Diagnosis, risk stratification ...... myeloproliferative neoplasms.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Diagnosis, risk stratification ...... l myeloproliferative neoplasms
@en
P2093
P2860
P304
P31
P356
10.1182/BLOOD-2016-10-695957
P407
P433
P478
P50
P577
P698
P921
P932